Viewing Study NCT05764161


Ignite Creation Date: 2025-12-24 @ 12:08 PM
Ignite Modification Date: 2025-12-27 @ 10:42 PM
Study NCT ID: NCT05764161
Status: COMPLETED
Last Update Posted: 2025-12-18
First Post: 2023-03-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
Sponsor: Incyte Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prurigo Nodularis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PN View
None INCB18424-320 View
None INCB18424 View
None Prurigo View
None Prurigo Nodularis View
None Skin Diseases View
None Dermatitis View
None ruxolitinib View